Team

Doug Cohen is IR Medtek's CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.

Andy Spector has over 30 years of experience in engineering, technical marketing, sales, and business development. He has extensive experience in fiber optics and integrated optics technologies. Andy is a graduate of Stanford (MS mechanical engineering) and University of Illinois (BS aeronautical engineering).

Dr. Siegle is a retired dermatologic surgeon whose area of specialization was diagnosis and management of skin cancer with special expertise in Mohs micrographic surgery and reconstructive plastic surgery. Previously, he was a Clinical Professor in both Dermatology and Otolaryngology at The Ohio State University. Dr. Siegle established the Center for Surgical Dermatology where he practiced until his retirement.

Dr. Siegle has degrees from Cornell (B.A.), Columbia (M.S.) and Upstate Medical College in New York (M.D.) and completed his Internship at St. Joseph Mercy Hospital in Ann Arbor Michigan and his Residency in Dermatology at the University of Michigan along with a Fellowship in Mohs and Dermatological Surgery at Duke University.

Dr. James Coe is a physical chemist whose research focuses on infrared spectroscopy to plasmonics in chemistry, physics, and biology. His other areas of research are infrared spectra, quantum mechanics, infrared microscope imaging, and big data analysis with how it applies to different systems, such as cancer detection

Dr. Coe received his B.A. with Honors in 1980 from Swarthmore College, and his PhD in 1986 from The Johns Hopkins University where he was awarded the Roseman Award for excellence in research. Postdoctoral work was done at the University of California, Berkeley and he has been a faculty member at The Ohio State University since 1989, being promoted to Associate Professor in 1995 and Full Professor in 2007 in the Department of Chemistry.

Dr. Hitchcock is an Emeritus Faculty member of the Dept. of Pathology at OSU and James Cancer Hospital. For the last 35 years, he has been a member of a multidisciplinary team of physicians, engineers, chemists, and biomedical scientists whose goal is to provide physicians with the resources to optimize the treatment of patients with solid tumors. Their efforts have resulted in over 500 publications and abstracts, multiple research grants, patents, and several biotech companies.

Dr. Hitchcock has degrees from Minnesota State University (B.A. and M.A), The Ohio State University (M.D.) and completed his Residency at the University of Florida in Pathology where he was a Clinical Fellow of the American Cancer Society. He also was a Cytology Fellow at the University of South Florida.

Dr. Allen received her BA in 1993 from UC Irvine and her PhD in 1997 where she worked with Nobel Laureate F. S. Rowland, and Professors D. Blake, J. Hemminger, and B. Finlayson-Pitts. She is a Professor in the Department of Chemistry and Biochemistry, and in the Department of Pathology.  Her research specialization is in molecular organization, ion pairing, and hydration at aqueous interfaces.

Dr. Bradley has a chemical physics background and was involved in initial development of this technology. She holds a PhD from The Ohio State University. Becky's thesis was focused on using spectroscopy and machine learning to develop methods for cancer detection using mid-infrared wavelengths.

Dr. Vazquez received her BS in 2015 and MS in 2017 in Chemistry from California State University, Los Angeles and her PhD in Analytical Chemistry from The Ohio State University in 2022. During her PhD she studied aqueous interfaces using interfacial-sensitive spectroscopy methods.